Marksans Pharma surges 20% after successful inspection of Goa plant by UK health regulator

NEW DELHI: Shares of Marksans Pharma surged nearly 20 per cent on Monday after the company informed bourses that an inspection by the UK health regulator from Feb 14-17 at the Goa plant has been completed without any critical observations.

The scrip was trading 19.70 per cent up at Rs 48.60 around 2.20 pm. Shares of the company opened at Rs 41.65 and touched a high and low of Rs 48.70 and Rs 41.65, respectively, in trade so far. Benchmark BSE Sensex was trading 125.21 points, or 0.44 per cent, up at 28,593.96.

In a BSE filing the company said, “We are pleased to announce that our plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa-403722 has had an inspected by UK MHRA from 14th February to 17 February. The same has been completed without any critical observations.”

On the BSE, 91.53 lakh shares were traded on the counter so far as against the average daily volumes of 6.58 lakh shares in the past two weeks.

Shares of the company hit their fresh 52-week high of Rs 58.30 on October 4, 2016 and 52-week low of Rs 33.45 on March 1, 2016.